The neurogenic basis of migraine - PubMed

Review

The neurogenic basis of migraine

F Michael Cutrer et al. Headache. 2008 Oct.

Abstract

There is accumulating evidence of a neurogenic basis of migraine. This evidence arises from both the clinical and experimental domains. Many of the well known clinical features of migraine attacks including the prodrome are not explained by changes in vascular caliber. Despite the fact that ergotamines and triptans are vasoactive does not provide substantive proof that vasoconstriction is their most important mechanism of action. Several effective treatments for migraine, both old and new, do not affect vascular caliber. Experimental evidence from investigation of both the aura and headache phases of migraine clearly supports a neural basis of migraine. All genes thus far conclusively associated with hemiplegic migraine code for neural proteins.

Similar articles

• An update on migraine pathophysiology and mechanism-based pharmacotherapeutics for migraine.

  Cady R, Biondi DM. Cady R, et al. Postgrad Med. 2006 Apr;Spec No:5-13. Postgrad Med. 2006. PMID: 17960686 Review.

• [Cerebral blood flow in migraine without aura].

  Bes A, Fabre N. Bes A, et al. Pathol Biol (Paris). 1992 Apr;40(4):325-31. Pathol Biol (Paris). 1992. PMID: 1495816 Review. French.

• Mast cells activate the renin angiotensin system and contribute to migraine: a hypothesis.

  Ba'albaki H, Rapoport A. Ba'albaki H, et al. Headache. 2008 Nov-Dec;48(10):1499-505. doi: 10.1111/j.1526-4610.2008.00852.x. Headache. 2008. PMID: 19076648 Review.

• Cortical spreading depression and estrogen.

  Eikermann-Haerter K, Kudo C, Moskowitz MA. Eikermann-Haerter K, et al. Headache. 2007 Sep;47 Suppl 2:S79-85. doi: 10.1111/j.1526-4610.2007.00818.x. Headache. 2007. PMID: 17850538 Review.

• [Migraine].

  Martins IP. Martins IP. Acta Med Port. 2009 Sep-Oct;22(5):589-98. Epub 2009 Oct 22. Acta Med Port. 2009. PMID: 19944043 Review. Portuguese.

Cited by

• Matrix metalloproteinases in neuropathic pain and migraine: friends, enemies, and therapeutic targets.

  Lakhan SE, Avramut M. Lakhan SE, et al. Pain Res Treat. 2012;2012:952906. doi: 10.1155/2012/952906. Epub 2012 Aug 28. Pain Res Treat. 2012. PMID: 22970361 Free PMC article.

• Migraine pain: reflections against vasodilatation.

  Panconesi A, Bartolozzi ML, Guidi L. Panconesi A, et al. J Headache Pain. 2009 Oct;10(5):317-25. doi: 10.1007/s10194-009-0130-6. Epub 2009 Jun 5. J Headache Pain. 2009. PMID: 19499287 Free PMC article. Review.

• Excitation-Inhibition Imbalance in Migraine: From Neurotransmitters to Brain Oscillations.

  O'Hare L, Tarasi L, Asher JM, Hibbard PB, Romei V. O'Hare L, et al. Int J Mol Sci. 2023 Jun 13;24(12):10093. doi: 10.3390/ijms241210093. Int J Mol Sci. 2023. PMID: 37373244 Free PMC article. Review.

• Whole-brain functional gradients reveal cortical and subcortical alterations in patients with episodic migraine.

  Lee CH, Park H, Lee MJ, Park BY. Lee CH, et al. Hum Brain Mapp. 2023 Apr 15;44(6):2224-2233. doi: 10.1002/hbm.26204. Epub 2023 Jan 17. Hum Brain Mapp. 2023. PMID: 36649309 Free PMC article.

• Triptans for the management of migraine.

  Johnston MM, Rapoport AM. Johnston MM, et al. Drugs. 2010 Aug 20;70(12):1505-18. doi: 10.2165/11537990-000000000-00000. Drugs. 2010. PMID: 20687618 Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wiley

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal